Chemoinformaics analysis of 29-methyltriacontan-1-ol
| Molecular Weight | 452.852 | nRot | 28 |
| Heavy Atom Molecular Weight | 388.34 | nRig | 0 |
| Exact Molecular Weight | 452.496 | nRing | 0 |
| Solubility: LogS | -7.665 | nHRing | 0 |
| Solubility: LogP | 12.864 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 96 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 64 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 31 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 95.2467 |
| nHD | 1 | BPOL | 64.2052 |
| QED | 0.117 |
| Synth | 1.703 |
| Natural Product Likeliness | 0.327 |
| NR-PPAR-gamma | 0.036 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -5.374 |
| MDCK | 0.00000279 |
| BBB | 0.002 |
| PPB | 0.99545 |
| VDSS | 4.705 |
| FU | 0.00825587 |
| CYP1A2-inh | 0.028 |
| CYP1A2-sub | 0.121 |
| CYP2c19-inh | 0.096 |
| CYP2c19-sub | 0.045 |
| CYP2c9-inh | 0.019 |
| CYP2c9-sub | 0.985 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.005 |
| CYP3a4-inh | 0.11 |
| CYP3a4-sub | 0.011 |
| CL | 4.847 |
| T12 | 0.008 |
| hERG | 0.511 |
| Ames | 0.006 |
| ROA | 0.005 |
| SkinSen | 0.981 |
| Carcinogencity | 0.014 |
| EI | 0.914 |
| Respiratory | 0.201 |
| NR-Aromatase | 0.095 |
| Antiviral | No |
| Prediction | 0.715 |